StreetAlpha.app
Home › Stocks › NTRA

Natera, Inc. (NTRA)

Healthcare
$287.47
▼ −0.35%
LAST CLOSE · NOV 17

Natera is a diagnostics company that offers blood tests for cancer, women's health and organ health. It last closed at $287.47 on Nov 17, down 0.35% on the day. NTRA last reported earnings on Thu, Nov 5, 2026. The average 12-month price target from 13 analysts is $443.31 (+54.2% from the last close), with a high of $500.00 and a low of $385.00. Analyst consensus is Strong Buy, based on the latest ratings from 13 firms (13 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in NTRA, 43% of them bullish and 57% bearish. In the past 30 days there were 10 dark pool prints totaling $16.0M, the largest $5.1M.

AI Auto Pilots
Is NTRA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.9B
+37.4% vs a year ago
Net income
−$164.7M
−5.7% margin
EPS (diluted)
−$1.12
Free cash flow
$52.5M
1.8% margin
Valuation
Market cap
$41.7B
145.0M shares
P/E
–
No P/E while losing money
Price to sales
14.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$1.1B
At Sep 30
Shareholder equity
$1.9B
Shares outstanding
145.0M
At Oct 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $625.5M$625.5MFY2021FY2022: $820.2M$820.2MFY2022FY2023: $1.1B$1.1BFY2023FY2024: $1.7B$1.7BFY2024FY2025: $2.3B$2.3BFY2025

From NTRA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · After the close (AMC)
Reported EPS
-$0.42
vs -$0.28 est. · miss
Year-ago EPS
—
Not on file
Options-implied move
±11.8%
Priced in before that report
Analyst consensus
Strong Buy
Based on 13 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
13firms
13 Buy0 Hold0 Sell
Each firm's latest rating on NTRA in the past 90 days
Average 12-month target
$443.31
▲ 54.2% upside

Based on 13 analysts who set a price target on NTRA in the past 90 days. The average target is $443.31, with a high of $500.00 and a low of $385.00, compared with the last close of $287.47.

Low $385.00Avg $443.31High $500.00
Blue marker: last close $287.47
Highest target$500.00
Average target$443.31
Lowest target$385.00
Latest rating changes
BairdMaintained
Nov 9Buy$403
JP MorganTarget lowered
Nov 6Buy$460 → $405
Evercore ISI GroupTarget raised
Nov 6Buy$360 → $400
BTIGTarget raised
Oct 27Buy$320 → $430
Canaccord GenuityTarget raised
Oct 19Buy$330 → $500
DateFirmActionRatingPrice target
Nov 9BairdMaintainedBuy$403
Nov 6JP MorganTarget loweredBuy$460 → $405
Nov 6Evercore ISI GroupTarget raisedBuy$360 → $400
Oct 27BTIGTarget raisedBuy$320 → $430
Oct 19Canaccord GenuityTarget raisedBuy$330 → $500
Loading…

Technical Analysis

NTRA · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, oversold

The stock is 27% below its 20 day and 32% below its 50 day average. It is 5% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 28), oversold. The nearest support is the Pivot at $287.07, and the nearest resistance the swing high (Jul 6) at $288.04.

Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.6%/day
Key levels
$437.4152 week high+52.2%
$378.1750 day average+31.6%
$365.6120 day average+27.2%
$335.84100 day average+16.8%
$296.78Pivot R1+3.2%
$288.04Swing high (Jul 6)+0.2%
$287.47Last close
$287.07Pivot−0.1%
$277.77Pivot S1−3.4%
$271.93200 day average−5.4%
$261.63Swing low (Jul 13)−9.0%
$181.0052 week low−37.0%
Indicators
RSI (14)28.21Oversold below 30Oversold
MACD-25.21Below its signal lineBearish
Stochastic6.0Near the bottom of its rangeOversold
ADX (14)40.9Strong downtrend
Williams %R-93.6Oversold below −80, overbought above −20Oversold
CCI (20)-119.3Oversold below −100, overbought above 100Oversold
Rate of change−26.0%Change over 10 sessionsBearish
ATR (14)$21.94Typical daily range, 7.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for NTRA

What happened before

See how NTRA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow is mixed3 bullish and 4 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow NTRA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How NTRA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
7
Bullish
3
43%
Bearish
4
57%
Date span
Sep 23 – Nov 5
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
10
Notional
$16.0M
Largest print
$5.1M
Loading…

NTRA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲515 buying vs 392 selling
  • ▼Held by funds -1.2 pts
  • ▲Funds holding +91
  • ▼Superinvestors: 1 added, 7 cut
  • ▼Put/call 0.15 to 3.16
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding943852+10.7%
In funds' top 102721+28.6%
Held by funds93.8%94.9%−1.2 pts
New / increased183 / 332154 / 358+0.6%
Reduced / sold out305 / 87242 / 68+26.5%
Put/call ratio3.160.15+1992.1%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NTRA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NTRA is in one of them and how their past NTRA trades turned out.

NTRA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NTRA in an article yet. Here's the latest on the wider market.

NTRA Congress Trades

All congress trades →
Trades, 12 months
5
Buys
3
60%
Sells
1
20%
People
1
Last filed Sep 22
Who traded NTRA · since 2021
Latest 5 filings of 12
$1K – $15KTraded Jul 17, 2026Filed Sep 22, 2026
$1K – $15KTraded May 18, 2026Filed Jul 1, 2026
$1K – $15KTraded May 15, 2026Filed Jul 1, 2026
$1K – $15KTraded Mar 17, 2026Filed May 14, 2026
$1K – $15KTraded Feb 19, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchBuy$1K – $15KJul 17, 2026Sep 22, 202667 d
Donald J TrumpExecutive branchBuy$1K – $15KMay 18, 2026Jul 1, 202644 d
Donald J TrumpExecutive branchBuy$1K – $15KMay 15, 2026Jul 1, 202647 d
Donald J TrumpExecutive branchSell$1K – $15KMar 17, 2026May 14, 202658 d
Donald J TrumpExecutive branchOther$1K – $15KFeb 19, 2026May 14, 202684 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Natera

Natera is a diagnostics company based in Austin, Texas, that uses blood tests built on genetic analysis to guide medical decisions. Its tests cover cancer, including Signatera, which tracks disease that may remain or return after treatment, women's health, including prenatal and hereditary cancer screening, and organ health, including transplant rejection and kidney disease. The company sells its tests directly in the United States and through laboratory partners worldwide, serving physicians, patients and cancer researchers.

Headquarters
Austin, TX
Founded
2004